|
|
||||||||
USDA, Agricultural Research Service, National Animal Disease Center, Periparturient Diseases of Cattle Research Unit, Ames, IA 50010-0070
2 Corresponding author: kkimura{at}nadc.ars.usda.gov
| ABSTRACT |
|---|
|
|
|---|
Key Words: endoplasmic reticulum flow cytometry immunosuppression signal transduction
| INTRODUCTION |
|---|
|
|
|---|
A key early feature in immune cell activation is an increase in intracellular ionized calcium concentration ([Ca2+]i), which acts as a second messenger of signal transduction (Grafton and Thwaite, 2001; Lewis, 2001). The degree of this initial rise in [Ca2+]i following an activation signal is an indicator of immune cell responsiveness and function (Partiseti et al., 1994; Baus et al., 1996). Some studies have shown that hypocalcemia in the rat can reduce hepatocyte intracellular Ca2+ pools, which blunts release of intracellular Ca2+ in response to hormones such as phenylephrine (Gascon-Barre et al., 1994, 1997; Mailhot et al., 2000). In their model, which utilized vitamin D-deficient rats, they found that decreased Ca stores in endoplasmic reticulum (ER) were associated with decreased Ca-binding proteins within hepatocytes (Mailhot et al., 2000).
The high Ca demand for milk production is often associated with hypocalcemia in dairy cows. This may affect the amount of releasable Ca2+ stored inside the ER of immune cells, thus impairing [Ca2+]i response to stimulation of bovine immune cells.
The data presented in this paper support the hypothesis that immune cells from cows with hypocalcemia have decreased intracellular Ca2+ storage, which is responsible for a blunted [Ca2+]i response to activation.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Measurement of Plasma Level of Ca
Plasma was isolated from heparinized blood samples and stored at 80°C until analysis. Plasma Ca concentration was determined by atomic absorption spectrophotometer (Perkin-Elmer, 1965).
Reagents to Measure Intracellular Ca by Flow Cytometry
The calcium-sensitive dyes, fluo-4-acetoxymethylester (AM) and Fura Red-AM, were obtained from Molecular Probes, Inc. (Eugene, OR). Fifty micrograms each of Fluo-4 and Fura Red were dissolved in 5 µL of anhydrous methyl sulfate (Aldrich Chemical Co., Inc., Milwaukee, WI), and kept in the dark at room temperature (
22°C). These stock solutions were used within 1 wk after preparation. Stock solutions were diluted with PBS (8.5 g of sodium chloride, 1.1 g of sodium phosphate dibasic, and 0.32 g of sodium phosphate monobasic in 1 L of H2O, pH = 7.2 ± 0.05) before use. Antibovine-CD3 mAb (mouse IgG1; VMRD Inc., Pullman, WA) was diluted with PBS (0.125 mg/mL) and stored at 4°C. Goat antiserum to mouse IgG (whole molecule, ICN, Aurora, OH) was reconstituted with sterilized distilled water to 10 mg/mL, and stored at 20°C until use. Pluronic F127 (Molecular Probes, Inc.) was dissolved in anhydrous methyl sulfate (with heating) to make a 20% (wt/vol) solution, and kept in the dark at room temperature. The working solution of Pluronic F127 was prepared by diluting stock solution 1/600 with PBS. Sodium orthovanadate (Sigma, St. Louis, MO) was dissolved in Krebs-Ringer bicarbonate/HEPES buffer (118.5 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 24.9 mM NaHCO3, 30 mM HEPES, pH = 6.8) to produce a 5 mM solution (Kadota et al., 1987). Pervanadate (4.2 mM) was made by mixing 5 volumes of sodium orthovanadate (5 mM) with 1 volume of 270 mM hydrogen peroxide. Pervanadate was added to cell preparations after 10 min of preparation and within 6 h to achieve a final concentration of 100 µM. Ionomycin was obtained from Calbiochem-Novabiochem Corp. (San Diego, CA) and dissolved in anhydrous methyl sulfate to make 1 mM solution and stored at 20°C until use. Ethylene glycol-bis (beta-aminoethyl-ether)-N,N,N',N'-tetra acetate (EGTA) buffer was prepared by dissolving 3-(N-morpholino)-propane-sulfonic acid (MOPS, 20 mM), KCl (140 mM), NaCl (20 mM), EGTA (0.1 mM) in H2O, pH = 6.8.
Measurement of [Ca2+]i by Measuring Fluo-4 and Fura Red Emission from PBMC
Fluo-4-acetoxymethylester emission increases with increasing cytosol-ionized calcium concentration, whereas Fura Red emission decreases with increasing cytosol-ionized calcium concentration. The [Ca2+]i response can be measured using Fluo-4 emission analysis alone. However, simultaneously measuring both the increase in Fluo-4 emission and the reduction in Fura Red emission with increasing free or ionized calcium content of cells during baseline and stimulated periods allows calculation of the change in Fluo-4 emission/change in Fura Red emission (Oishi et al., 2001). This calculation results in a determination of [Ca2+]i response with less variation than using Fluo-4 emission alone. We determined this previously by using PBMC from 5 nonparturient cows obtained over 5 consecutive days with assays performed in triplicate (data not shown). The intraassay coefficients of variation for the [Ca2+]i response to anti-CD3 mAb plus secondary anti-bodies (Ab) were determined. The Fluo-4 and Fluo-4/Fura Red ratios were 7.1 ± 1.0 and 5.7 ± 1.2%, respectively. Interassay variations were 13.3 ± 1.6 and 10.7 ± 2.1% for Fluo-4 and Fluo-4/Fura Red ratio, respectively. Therefore, all data on [Ca2+]i response to stimulation are expressed on the basis of the Fluo-4/Fura Red ratio.
Loading Dyes into Cells for [Ca2+]i Measurement
Within 1 h after collecting a blood sample in acid citrate dextrose, 200-µL aliquots of whole blood were dispensed into a microtiter plate (U-shaped bottom, 96-well). The plate was centrifuged at 500 x g for 2 min and supernatant plasma was discarded. Red blood cells were lysed by adding 200 µL of hypotonic lysing solution for 15 s. Isotonicity was restored by adding 100 µL of restoring solution (Burton and Kehrli, 1995). After centrifugation at 500 x g for 2 min, the supernatant was discarded, and the lysing process repeated. The remaining leukocytes were washed once with 200 µL of PBS. Fluo-4-acetoxymethylester (final concentration of 2.8 µM) and Fura Red-AM (final concentration of 5.7 µM) were added to cells together with Pluronic F127 (final concentration of 0.06%). Pluronic F127 helps the calcium-detecting dyes to enter the leukocytes. Upon entry into cells, the AM group is cleaved from the Fluo-4-AM and Fura Red-AM by various esterases and the deesterified Fluo-4 and Fura Red are trapped inside the cell, and can bind Ca2+ in the cytosol (Tsien, 1981). The cells were incubated for 30 min at 39°C in a humidified CO2 (5%) chamber. After loading the dyes, 100 µL of PBS was added, the plate was centrifuged at 500 x g for 2 min, and the supernatant was discarded to remove dye that had not entered the cells. Cells were washed once more with 200 µL of Hanks balanced salt solution (HBSS) with 1.2 mM CaCl2 and resuspended in 200 µL of the wash solution. When estimating ER Ca storage following pervanadate and ionomycin stimulation the EGTA buffer, which was free of calcium, was used in place of HBSS with CaCl2 to eliminate the possibility of extracellular Ca2+ entering the cells and contributing to changes in [Ca2+]i.
Activation of PBMC to Measure [Ca2+]i Response Capability
The cell suspension in each well was transferred into a tube, which contained 300 µL of HBSS with 1.2 mM CaCl2 to simulate normal blood ionized calcium content. For activation of the cells by the CD3 stimulation pathway, anti-CD3 mAb (final concentration of 1 µg/mL) was added at this stage (before activation). All tubes were maintained at 39°C using a block heater for 5 to 6 min before acquisition of data. Measurements of fluorescence were performed with a flow cytometer (FACScan, Becton Dickinson, San Jose, CA) using an argon-ion laser for excitation. Peripheral blood mono-nuclear cells were gated from debris and neutrophils based on forward vs. side scatter of light (Kimura et al., 1999). The Fluo-4 and Fura Red dyes were excited at 488 nm; Fluo-4 emission was detected at 515 to 535 nm and Fura Red emission was detected at 665 to 685 nm.
Peripheral blood mononuclear cells were analyzed at 39°C at a flow rate of 400 cells/s. Baseline, unstimulated measurements of Fluo-4/Fura Red ratio were made for 20 s. Then, intracellular Ca2+ release was measured in response to addition of goat antimouse IgG. The binding of the goat antimouse antibody to the anti-CD3 mAb completes initiation of PBMC activation (Vassilopoulos et al., 1997). Measurement of Fluo-4 and Fura Red emission was continued for an additional 90 s. The fold change in Fluo-4/Fura Red ratio between baseline and stimulated PBMC was calculated for each well.
Estimation of ER Ca2+ Stores
To estimate ER Ca stores, pervanadate was added to cells after the baseline measurements instead of anti-CD3 mAb-secondary Ab complex. The cells were also maintained in the calcium-free EGTA buffer, and [Ca2+]i was measured for the next 150 s. The pervana-date solution contained hydrogen peroxide, which activates PBMC by stimulating tyrosine kinases (Schieven and Ledbetter, 1994). Pervanadate interferes with calcium-ATPases of cell plasma membrane and ER membrane (Fantus et al., 1989), preventing calcium released to the cytosol from ER (or entering the cell from the extracellular fluids) from being returned to the ER or pumped to the extracellular fluids. Consequently, Ca2+ builds up within the cytosol of the cell until the ER is exhausted of its releasable Ca2+ stores. This was followed by ionomycin treatment (1 µM) of the same cells for the next 150 s during which time [Ca2+]i was measured. Ionomycin, a Ca ionophore, opens calcium channels in membranes including the cell membrane and the ER membrane and represents a second means of ensuring total releasable Ca stored within organelles has been released to the cytosol. Because this assay was performed in Ca-free medium, there is no contribution of extracellular Ca2+ to any increase in [Ca2+]i measured by this method (Telford and Miller, 1996; Salvador and Mata, 1998). The change in Fluo-4/Fura Red ratio between baseline and pervanadate/ionomycin-stimulated periods was calculated for each well (Roderick et al., 1998).
Analysis of Flow Cytometry Data
The data were stored in a "list mode" format and then Fluo-4 or Fura Red vs. time was analyzed using Cell Quest (Becton Dickinson) and saved as flow cytometry standard mode. Kinetic analysis of Fluo-4 or Fluo-4/Fura Red ratio vs. time as mean value of individual cells was done using Flow Jo software (Tree Star, Inc., San Carlos, CA) to determine peak response in [Ca2+]i flux when anti-CD3 mAb-secondary Ab complex was the stimulant, and area under the curve of Fluo-4/Fura Red ratio over time to determine Fluo-4/Fura Red ratio when pervanadate/ionomycin were used to estimate releasable ER Ca2+ stores.
Statistical Analysis
Data were analyzed by repeated measures using the PROC MIXED of SAS (version 9.1, SAS Inst., Inc., Cary, NC). The model included the fixed effects of disease status (milk fever vs. nonmilk fever), day (time around parturition), and disease status x day interaction, the random effect of cows nested within disease status, and the residual error. For each variable analyzed, cow nested within treatment was subjected to 3 covariance structures: compound symmetry, autoregressive order 1, and unstructured covariance. The covariance that resulted in the Akaikes information criterion closest to zero was used. In all cases, it was the autoregressive order 1 covariance structure. Means and SEM are reported for all data. When significant effects (P < 0.05) due to disease status, day, or disease status x day interactions were detected, means separation was conducted by the Duncan-Hsu option in SAS. Correlation analysis was done using the CORR procedure of SAS using data from d 11, 0, and 11 to see if significant correlations existed between [Ca2+]i response and the level of releasable ionized Ca stored in the ER. We also analyzed for correlations between plasma Ca and the [Ca2+]i response or the level of releasable ionized Ca stored in the ER. The mean lymphocyte [Ca2+]i responses to stimulation before and after intravenous calcium infusion into milk fever cows were compared by Students 2-tailed t-test.
| RESULTS |
|---|
|
|
|---|
Plasma Ca Concentration
Plasma Ca concentrations of MF and NMF cows during the periparturient period are shown in Figure 1
. The Ca concentration was maintained within normal limits (8.5 to 9.5 mg/dL) until around the time of calving, when it dropped dramatically with the nadir the day of calving or the day after (NMF: 7.3 ± 0.2 mg/dL, MF: 4.7 ± 0.3 mg/dL). Plasma Ca concentrations returned to nearly normal levels by d 4. Repeated measures ANOVA found significant time (P < 0.0001), milk fever (P = 0.003), and time x milk fever interaction effects (P < 0.0001).
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Stimulation of PBMC by anti-CD3 mAb-secondary Ab complex starts an activation cascade, which involves activation of tyrosine kinases that then phosphorylate phospholipase C-
. Phosphorylated phospholipase C-
hydrolyzes inositol phospholipids in cell membranes, resulting in release of inositol 1,4,5-trisphosphate generation. Inositol 1,4,5-trisphosphate binds to receptors on the ER stimulating release of Ca2+ stored within the ER to the cytosol. This release of Ca2+ stored inside the ER can then stimulate an influx of extracellular Ca2+ into the cytosol via Ca2+ release-activated Ca2+ channels (Kurosaki, 1999; Lewis, 2001). The reduced [Ca2+]i response to anti-CD3 mAb-secondary Ab complex stimulation observed in PBMC from periparturient cows (Figure 2
) occurs at the same time as a reduction in other PBMC functions in periparturient cows (Kehrli et al., 1989a; Nonnecke et al., 2003). These data suggest that the decrease in PBMC functions seen as parturition approaches and their recovery after parturition may be the result of reduced PBMC [Ca2+]i responsiveness.
Intracellular calcium signaling is a critical element for immune cell activation and functions. It regulates cell proliferation, cytokine production, and cytokine receptor expression as well as other cell functions (Partiseti et al., 1994; Allen et al., 1995; Carruthers et al., 1996, 2000). Individuals with conditions such as rheumatoid arthritis of inflammatory bowel disease often have lymphocytes with depressed IL-2 production and IFN-
secretion. These lymphocytes also exhibit a depressed rise in [Ca2+]i in response to mitogen or anti-CD3 stimulation. This blunted response was also directly correlated with diminished lymphocyte proliferation activity (Allen et al., 1995). Such individuals with rheumatoid arthritis of inflammatory bowel disease do not have hypocalcemia; however, their lymphocytes do seem to have problems with distribution of calcium in the ER and other organelles, which prevents adequate calcium release.
The question arises as to the cause of the reduced PBMC [Ca2+]i response to stimuli in periparturient cows. Shortly after MF cows were treated with an i.v. infusion of Ca, there was a significant increase in PBMC [Ca2+]i flux in response to stimulation by anti-CD3 mAb-secondary Ab complex (Figure 3
). Because the initial rise in [Ca2+]i is caused by efflux of stored calcium from the ER followed by influx of extracellular Ca2+ and because this flux of Ca2+ goes on to open the Ca2+ release-activated Ca2+ channels needed to bring in extracellular Ca2+, we hypothesized that the decreased PBMC [Ca2+]i responsiveness may be due to a decrease in ER calcium storage in the PBMC of periparturient cows. Using PBMC treated with a combination of pervanadate and ionomycin, we were able to demonstrate that the amount of ER Ca available for release to the cytosol decreases around the time of calving, which corresponds to the time when hypocalcemia is most commonly observed in cows. There was a good correlation between [Ca2+]i responsiveness and amount of releasable Ca2+ stored inside the ER. The decrease in releasable Ca2+ stored within the ER was not necessarily well correlated with hypocalcemia, especially during the 1 to 2 wk before calving. Endoplasmic reticulum Ca2+ stores were being depleted in MF cows many days before the development of hypocalcemia and milk fever. These data suggest that intracellular Ca stores were being utilized to help sustain extracellular Ca or that when the cow is struggling to maintain Ca homeostasis (as colostrum is being formed within the mammary gland), the ability to keep ER Ca stores fully stocked is compromised. This observation suggests that the decreased [Ca2+]i response is because of a decrease in the amount of releasable Ca2+ stored inside the ER of PBMC as the cow approaches parturition.
Our data showed that extracellular calcium status affects PBMC cellular calcium stores and thus, cellular calcium flux in response to signaling activation. These findings are in agreement with the data of Mailhot et al. (2000), who showed that hepatocytes isolated from hypocalcemic rats exhibited decreased [Ca2+]i flux in response to hormone stimulation, even when cells were suspended in media with normal extracellular Ca2+ concentration in vitro during hormone stimulation. Our data further challenge the prevailing hypothesis that extracellular Ca2+ has no significant impact on cellular Ca2+ by demonstrating that, despite the large Ca2+ gradient between extra- and intracellular Ca2+ concentrations, calcium deficiency in vivo significantly alters the response of immune cells to an activation stimulus.
Our data suggest that increased demand for Ca at the end of gestation and the onset of lactation results in decreased releasable Ca2+ stored inside ER in spite of well-maintained plasma calcium concentration up to parturition. We speculate that the immense demand for calcium before calving contributes to decreased intracellular Ca2+ stores even before hypocalcemia develops. Hypocalcemia at parturition further exacerbates the decline in the PBMC releasable Ca2+ stores. Because MF cows suffered the greater degree of hypocalcemia, the amount of Ca stored in their PBMC ER was lower and the flux of Ca2+ out of the ER in response to PBMC activation was smaller than in NMF cows. Further studies are needed to determine the mechanism of intracellular Ca2+ storage depletion and whether it might be associated with decreased Ca binding proteins as reported in rat hepatocytes (Mailhot et al., 2000).
| CONCLUSIONS |
|---|
|
|
|---|
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
Received for publication December 2, 2005. Accepted for publication February 2, 2006.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. D. Lippolis Immunological signaling networks: Integrating the body's immune response J Anim Sci, April 1, 2008; 86(14_suppl): E53 - E63. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |